Anthem wants Supreme Court to review blocked Cigna deal

Anthem is taking its blocked $54 billion acquisition of Cigna to the U.S. Supreme Court, asking the highest court to review the rejection by a federal appeals court.

According to a press release from Anthem, it feels the 2-1 decision offers an opening to save the deal. In his dissenting opinion, Judge Brett Kavanaugh said he agreed with Anthem’s argument that the merger would produce efficiencies benefiting “employer-customers who obtain insurance services from Anthem and Cigna.”

He didn’t say these efficiencies were enough to resolve all antitrust issues, and stated he would’ve sent the case back to the U.S. District Court to weigh in on potential anti-competitive effects in the insurer’s dealings with providers.

“Citing the circuit split over the consideration of efficiencies in merger analysis, Anthem urges that 1960s-era merger precedents relied upon by the courts below must be updated to reflect the modern understanding of economics and consumer benefit,” Anthem said in a statement.

The Anthem-Cigna deal was blocked in February. Cigna responded by suing Anthem for $15 billion in damages, including the $1.85 billion breakup fee. Anthem has continued pursuing the acquisition, losing its appeal on April 28 in a decision applauded by several major medical associations.

“If the deal moved forward, insurers would have less of an incentive to work with hospitals on innovative arrangements to improve care throughout the delivery system for patients,” said American Hospital Association President and CEO Rick Pollack. “In addition, Anthem’s use of market power against providers would have put access to and the quality of health care at risk.”

The request for a review, called a writ of certiorari, is typically answered by the Supreme Court within six weeks.

As is always the case with the Supreme Court, the odds are against the justices even taking up Anthem’s request. The court typically takes up only 80 of the more than 7,000 cases its requested to hear every year.

Analyst Michael Newshel of Evercore ISI doesn’t expect the high court to overturn the previous ruling. In his prediction to StreetInsider, he said the merger will likely break, and to expect “continued litigation or settlement over the breakup fee."

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."

Trimed Popup
Trimed Popup